Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimicrobial ear drop medication therapy

K Suzuki1, S Baba

  • 1Department of Otolaryngology, Nagoya City University Medical School, Japan.

Acta Oto-Laryngologica. Supplementum
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of cellular signals by calpain.

Annals of the New York Academy of Sciences·1992
Same author

Influence of oxidative stress on induced tolerance to ischemia in gerbil hippocampal neurons.

Brain research·1992
Same author

Positive regulation of mu-calpain action by polyphosphoinositides.

The Journal of biological chemistry·1992
Same author

[Conditions for low-intensity voluntary wheel running in rats and its chronic effects on health indexes].

Nihon eiseigaku zasshi. Japanese journal of hygiene·1992
Same author

Fluorescent probe-labeled lipid microsphere uptake by human endothelial cells: a flow cytometric study.

Japanese journal of pharmacology·1992
Same author

[Antibacterial activity of rokitamycin against fresh clinical isolates].

The Japanese journal of antibiotics·1992
Same journal

Towards a consensus on a hearing preservation classification system.

Acta oto-laryngologica. Supplementum·2013
Same journal

Inner ear drug delivery system from the clinical point of view.

Acta oto-laryngologica. Supplementum·2010
Same journal

Hydrogen protects vestibular hair cells from free radicals.

Acta oto-laryngologica. Supplementum·2010
Same journal

Distribution of bone marrow-derived cells in the vestibular end organs and the endolymphatic sac.

Acta oto-laryngologica. Supplementum·2010
Same journal

Impacts and limitations of medialization thyroplasty on swallowing function of patients with unilateral vocal fold paralysis.

Acta oto-laryngologica. Supplementum·2010
Same journal

A tissue-engineering approach for stenosis of the trachea and/or cricoid.

Acta oto-laryngologica. Supplementum·2010
See all related articles

New ear drop antibiotics, including cefmenoxime and ofloxacin, show high bacterial eradication rates. Researchers recommend limiting otic drug treatment duration to four weeks to avoid potential side effects.

Area of Science:

  • Otolaryngology
  • Pharmacology
  • Infectious Diseases

Background:

  • Ear drop medications offer targeted drug delivery to lesions, enhancing efficacy and minimizing systemic side effects.
  • Evaluating novel antibacterial agents for otic use is crucial, especially those with no documented ototoxicity.

Purpose of the Study:

  • To assess the effectiveness of three new antibacterial agents: cefmenoxime (CMX), fosfomycin (FOM), and ofloxacin (OFLX), for ear infections.
  • To determine bacterial eradication rates, persistence rates, and fungal infection rates for these agents.
  • To provide guidance on optimal treatment duration for otic antibacterial drugs.

Main Methods:

  • Clinical evaluation of cefmenoxime (CMX), fosfomycin (FOM), and ofloxacin (OFLX) ear drop medications.
  • Measurement of bacterial eradication rates, bacterial persistence rates, and fungal infection rates.

Related Experiment Videos

  • Comparison of efficacy data with lomefloxacin (LFLX) over a one-week treatment period.

    • Main Results:

    • Cefmenoxime (CMX) demonstrated a 91.4% bacterial eradication rate with a 2.9% persistence rate.
    • Ofloxacin (OFLX) achieved an 88.4% eradication rate and a 4.7% persistence rate.
    • Fosfomycin (FOM) showed a 71.2% eradication rate and a 20.9% persistence rate, with a 7.0% fungal infection rate for all tested agents.

    Conclusions:

    • Cefmenoxime (CMX) and ofloxacin (OFLX) are highly effective antibacterial agents for ear drop treatment.
    • A treatment duration exceeding four weeks for any single otic drug is not advisable.
    • Careful consideration of treatment duration is recommended to optimize outcomes and minimize risks associated with otic antibacterial therapy.